Mutual of America Capital Management LLC Takes $947,000 Position in Inspire Medical Systems, Inc. (NYSE:INSP)

Mutual of America Capital Management LLC acquired a new stake in Inspire Medical Systems, Inc. (NYSE:INSP - Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 4,485 shares of the company's stock, valued at approximately $947,000.

Other large investors also recently modified their holdings of the company. Price T Rowe Associates Inc. MD raised its position in shares of Inspire Medical Systems by 51.8% in the first quarter. Price T Rowe Associates Inc. MD now owns 459,766 shares of the company's stock valued at $98,754,000 after purchasing an additional 156,893 shares during the period. Tidal Investments LLC bought a new position in Inspire Medical Systems during the first quarter worth about $1,151,000. AQR Capital Management LLC increased its position in Inspire Medical Systems by 152.7% during the second quarter. AQR Capital Management LLC now owns 231,845 shares of the company's stock worth $31,028,000 after acquiring an additional 140,090 shares during the period. Teachers Retirement System of The State of Kentucky increased its position in Inspire Medical Systems by 27.1% during the first quarter. Teachers Retirement System of The State of Kentucky now owns 40,501 shares of the company's stock worth $8,699,000 after acquiring an additional 8,625 shares during the period. Finally, SG Americas Securities LLC increased its position in Inspire Medical Systems by 114.2% during the second quarter. SG Americas Securities LLC now owns 6,228 shares of the company's stock worth $833,000 after acquiring an additional 3,321 shares during the period. 94.91% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of research firms recently commented on INSP. Bank of America raised shares of Inspire Medical Systems from a "neutral" rating to a "buy" rating and raised their price target for the stock from $220.00 to $255.00 in a research report on Wednesday, November 20th. Royal Bank of Canada reaffirmed an "outperform" rating and set a $260.00 price target on shares of Inspire Medical Systems in a research report on Tuesday, November 5th. KeyCorp lowered their price target on shares of Inspire Medical Systems from $278.00 to $236.00 and set an "overweight" rating on the stock in a research report on Wednesday, August 7th. Leerink Partners raised their target price on shares of Inspire Medical Systems from $167.00 to $197.00 and gave the company a "market perform" rating in a report on Tuesday, September 10th. Finally, Wells Fargo & Company raised their target price on shares of Inspire Medical Systems from $187.00 to $198.00 and gave the company an "equal weight" rating in a report on Tuesday, November 5th. Three equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average target price of $233.58.

Insider Activity

In related news, Director Shawn Mccormick sold 800 shares of Inspire Medical Systems stock in a transaction that occurred on Monday, September 9th. The shares were sold at an average price of $220.00, for a total transaction of $176,000.00. Following the sale, the director now directly owns 23,140 shares in the company, valued at $5,090,800. This trade represents a 3.34 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 4.10% of the stock is currently owned by corporate insiders.

Inspire Medical Systems Trading Down 5.2 %

INSP opened at $189.05 on Wednesday. The company's 50 day moving average is $199.01 and its 200-day moving average is $175.73. Inspire Medical Systems, Inc. has a 1-year low of $123.00 and a 1-year high of $257.40. The company has a market cap of $5.67 billion, a P/E ratio of 176.68 and a beta of 1.36.

Inspire Medical Systems (NYSE:INSP - Get Free Report) last posted its quarterly earnings results on Monday, November 4th. The company reported $0.60 earnings per share for the quarter, beating analysts' consensus estimates of $0.06 by $0.54. Inspire Medical Systems had a net margin of 4.37% and a return on equity of 5.30%. The company had revenue of $203.20 million for the quarter, compared to the consensus estimate of $197.59 million. During the same period last year, the company posted ($0.29) EPS. The firm's quarterly revenue was up 32.6% compared to the same quarter last year. On average, equities analysts forecast that Inspire Medical Systems, Inc. will post 1.33 EPS for the current year.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.